Rydapt Interactions
There are 651 drugs known to interact with Rydapt (midostaurin), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 143 are major, 503 are moderate, and 5 are minor.
- View all 651 medications that may interact with Rydapt
- View Rydapt alcohol/food interactions (1)
- View Rydapt disease interactions (2)
Most frequently checked interactions
View interaction reports for Rydapt (midostaurin) and the medicines listed below.
- acyclovir
- Afinitor (everolimus)
- allopurinol
- amiodarone
- amlodipine
- atorvastatin
- Entresto (sacubitril / valsartan)
- Farxiga (dapagliflozin)
- Gleevec (imatinib)
- Jadenu (deferasirox)
- Jakafi (ruxolitinib)
- Kisqali (ribociclib)
- levofloxacin
- levothyroxine
- magnesium oxide
- Mekinist (trametinib)
- metformin
- olanzapine
- ondansetron
- Ozempic (semaglutide)
- pantoprazole
- potassium chloride
- prochlorperazine
- Promacta (eltrombopag)
- promethazine
- Sandostatin (octreotide)
- spironolactone
- Tasigna (nilotinib)
- torsemide
- Tykerb (lapatinib)
Rydapt alcohol/food interactions
There is 1 alcohol/food interaction with Rydapt (midostaurin).
Rydapt disease interactions
There are 2 disease interactions with Rydapt (midostaurin) which include:
Report options
QR code containing a link to this page
More about Rydapt (midostaurin)
- Rydapt consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
